HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Topsiders Must Testify In Plan B Case – Judge

This article was originally published in The Tan Sheet

Executive Summary

The Center for Reproductive Rights will be allowed to take depositions from certain FDA "senior decision-makers" in their suit against the agency over decisions related to emergency contraceptive Plan B

You may also be interested in...



FDA Depositions Reveal Crawford’s Prominent Role In Plan B Switch Review

The role of high-level FDA officials in the review of Barr Labs' Rx-to-OTC switch application for Plan B was required by the "high-profile" nature of the NDA, according to Center for Drug Evaluation & Research Director Steven Galson

FDA Must Take Action On Omnitrope Review, Court Says; Will Plan B Follow?

The case against FDA over the Plan B switch review delay will likely benefit from the precedent of a D.C. federal court ruling April 10 upholding PDUFA review deadlines as mandatory

Wisconsin “Lacks Standing” To Become Plaintiff In Plan B Lawsuit – FDA

A federal judge in the Plan B lawsuit against FDA has granted the agency an additional three weeks to respond to the state of Wisconsin's request to become a plaintiff in the suit, but will not prevent the state from deposing agency officials in the case

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS125926

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel